Literature DB >> 17095305

Imprinting center analysis in Prader-Willi and Angelman syndrome patients with typical and atypical phenotypes.

Cristina Camprubí1, Maria Dolors Coll, Sergi Villatoro, Elisabeth Gabau, Amine Kamli, Maria Jesus Martínez, David Poyatos, Miriam Guitart.   

Abstract

Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are genetic disorders caused by a deficiency of imprinted gene expression from the paternal or maternal chromosome 15, respectively. This deficiency is due to the deletion of the 15q11-q13 region, parental uniparental disomy of the chromosome 15, or imprinting defect (ID). Mutation of the UBE3A gene causes approximately 10% of AS cases. In this present study, we describe the molecular analysis and phenotypes of two PWS patients and four AS patients with ID. One of the PWS patients has a non-familial imprinting center (IC) deletion and displayed a severe phenotype with an atypical PWS appearance, hyperactivity and psychiatric vulnerability. The other PWS and AS patients did not present genetic abnormalities in the IC, suggesting an epimutation as the genetic cause. The methylation pattern of two AS patients showed a faint maternal band corresponding to a mosaic ID. One of these mosaic patients displayed a mild AS phenotype while the other displayed a PWS-like phenotype.

Entities:  

Mesh:

Year:  2006        PMID: 17095305     DOI: 10.1016/j.ejmg.2006.10.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  7 in total

1.  Prader-Willi and Angelman syndromes: genetic counseling.

Authors:  Cristina Camprubí; Maria Dolors Coll; Elisabeth Gabau; Míriam Guitart
Journal:  Eur J Hum Genet       Date:  2009-10-07       Impact factor: 4.246

2.  An atypical case of hypomethylation at multiple imprinted loci.

Authors:  Emma L Baple; Rebecca L Poole; Sahar Mansour; Catherine Willoughby; I Karen Temple; Louise E Docherty; Rohan Taylor; Deborah J G Mackay
Journal:  Eur J Hum Genet       Date:  2011-01-05       Impact factor: 4.246

3.  Epigenetic regulatory mechanisms associated with infertility.

Authors:  Sheroy Minocherhomji; Prochi F Madon; Firuza R Parikh
Journal:  Obstet Gynecol Int       Date:  2010-08-05

4.  Preserved expressive language as a phenotypic determinant of Mosaic Angelman Syndrome.

Authors:  Robert P Carson; Lynne Bird; Anna K Childers; Ferrin Wheeler; Jessica Duis
Journal:  Mol Genet Genomic Med       Date:  2019-08-10       Impact factor: 2.183

Review 5.  A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome.

Authors:  Jessica Duis; Mark Nespeca; Jane Summers; Lynne Bird; Karen G C B Bindels-de Heus; M J Valstar; Marie-Claire Y de Wit; C Navis; Maartje Ten Hooven-Radstaake; Bianca M van Iperen-Kolk; Susan Ernst; Melina Dendrinos; Terry Katz; Gloria Diaz-Medina; Akshat Katyayan; Srishti Nangia; Ronald Thibert; Daniel Glaze; Christopher Keary; Karine Pelc; Nicole Simon; Anjali Sadhwani; Helen Heussler; Anne Wheeler; Caroline Woeber; Margaret DeRamus; Amy Thomas; Emily Kertcher; Lauren DeValk; Kristen Kalemeris; Kara Arps; Carol Baym; Nicole Harris; John P Gorham; Brenda L Bohnsack; Reid C Chambers; Sarah Harris; Henry G Chambers; Katherine Okoniewski; Elizabeth R Jalazo; Allyson Berent; Carlos A Bacino; Charles Williams; Anne Anderson
Journal:  Mol Genet Genomic Med       Date:  2022-02-11       Impact factor: 2.183

6.  Atypical presentation of Angelman syndrome with intact expressive language due to low-level mosaicism.

Authors:  Ruchi Punatar; Alena Egense; Rong Mao; Melinda Procter; Michelle Bosworth; Denise I Quigley; Kathleen Angkustsiri; Suma P Shankar
Journal:  Mol Genet Genomic Med       Date:  2022-08-04       Impact factor: 2.473

7.  Patients with mosaic methylation patterns of the Prader-Willi/Angelman Syndrome critical region exhibit AS-like phenotypes with some PWS features.

Authors:  Umut Aypar; Nicole L Hoppman; Erik C Thorland; D Brian Dawson
Journal:  Mol Cytogenet       Date:  2016-03-22       Impact factor: 2.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.